Brett Matthew Hall serves as Executive at Immuneering Corp, where they oversee executive responsibilities. Since joining the company, Brett Matthew Hall has executed 10 insider transactions totaling $69.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 3, 2026 involved receiving (via award) 344,000 shares valued at $0.
Brett Matthew Hall currently holds 344,000 shares of Immuneering Corp (IMRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brett Matthew Hall has been a net buyer of IMRX stock. They have purchased $69.1K and sold $0 worth of shares.
Brett Matthew Hall's most recent insider trade was on Feb 3, 2026, when they sold 344,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $4.57 |
| Discretionary |
| Sep 15, 2025 | IMRX | $21.3K | Award | 14,880 | $1.43 | Discretionary |
| Mar 20, 2024 | IMRX | $20.0K | Purchase | 7,000 | $2.86 | Discretionary |
| Mar 15, 2024 | IMRX | $10.1K | Award | 6,211 | $1.62 | Discretionary |
| May 25, 2022 | IMRX | $10.0K | Purchase | 2,551 | $3.92 | Discretionary |
| Mar 23, 2022 | IMRX | $8.3K | Purchase | 1,050 | $7.91 | Discretionary |
| Dec 22, 2021 | IMRX | $0 | Award | 322,691 | $N/A | Discretionary |
| Aug 3, 2021 | IMRX | $0 | Conversion | 5,040 | $N/A | Discretionary |
| Aug 3, 2021 | IMRX | $20.3K | Purchase | 1,353 | $15.00 | Discretionary |